Daewoong Pharma
KRX:069620
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Daewoong Pharma
KRX:069620
|
KR |
Intrinsic Value
The intrinsic value of Daewoong Pharma (069620) under the Base Case is 194 058.1 KRW per share.
Compared with the current market price of 99 100 KRW, the stock appears
Undervalued by 49% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Daewoong Pharma Does
Daewoong Pharma is a South Korean drugmaker that develops, manufactures, and sells prescription medicines and other healthcare products. Its core business is making finished medicines that are used by hospitals, clinics, and pharmacies, along with some consumer health products sold over the counter. The company also works on pharmaceutical research and formulation, which helps it create and improve medicines for common medical needs.
- Headquarters
- Korea KR
- IPO date
- Nov 1, 2002
Revenue & Expenses Breakdown
Daewoong Pharma
Earnings Waterfall
Daewoong Pharma
The intrinsic value for Daewoong Pharma (069620) under the Base Case is 194 058.1 KRW.
Compared with the current market price of 99 100 KRW, the stock appears Undervalued by 49% .